Onderzoeker
Robin Maximilian Awad
- Onderzoeksexpertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
- Trefwoorden:Geneeskunde
- Disciplines:Medische en gezondheidswetenschappen, Sociale wetenschappen
- Gebruikers van onderzoeksexpertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
Affiliaties
- Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf19 mrt 2021 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 nov 2019 → 31 aug 2023 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → 31 okt 2019 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → 31 okt 2019 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf11 sep 2018 → 14 jun 2023 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf30 sep 2015 → 27 jun 2018
Projecten
1 - 1 of 1
- Versterken van de functie van kanker tegenwerkende effector cellen met behulp van nanobodies specifiek voor regulerende immuun controle puntenVanaf1 nov 2019 → 31 okt 2023Financiering: FWO mandaten
Publicaties
1 - 10 van 14
- Novel technologies for applying immune checkpoint blockers(2024)Series: International Review of Cell and Molecular Biology
Auteurs: R M Awad, K Breckpot
Aantal pagina's: 100 - In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Auteurs: R M Awad, Y De Vlaeminck, Fien Meeus, T Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, G Raes, et al.
Pagina's: 1-13 - Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT(2023)
Auteurs: Katty Zeven, Timo W M De Groof, Hannelore Ceuppens, R M Awad, T Ertveldt, Wout De Mey, Fien Meeus, G Raes, K Breckpot, Nick Devoogdt
- Eccentric(2023)
Auteurs: R M Awad, K Breckpot, Nick Devoogdt, Y De Vlaeminck
Aantal pagina's: 208 - Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Auteurs: Máté Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, R M Awad, Yvon Elkrim, et al.
- Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model(2022)
Auteurs: T Ertveldt, L De Beck, Kirsten De Ridder, Hanne Locy, Wout De Mey, Cleo Goyvaerts, Q Lecocq, Hannelore Ceuppens, Y De Vlaeminck, R M Awad, et al.
Pagina's: 1136-1148 - Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma(2022)
Auteurs: L De Beck, R M Awad, Veronica Basso, Noelia Casares, Kirsten De Ridder, Y De Vlaeminck, Alessandra Gnata, Cleo Goyvaerts, Q Lecocq, Edurne San José-Enériz, et al.
Pagina's: 1-15 - TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy(2022)
Auteurs: Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Ibarra Zuazo, R M Awad, Stefaan Verhulst, Mathias Van Bulck, Y De Vlaeminck, Q Lecocq, Eva Reijmen, et al.
Pagina's: 1-15 - Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays(2022)
Auteurs: Kirsten De Ridder, Navpreet Tung, Jan-Timon Werle, Léa Karpf, R M Awad, Annie Bernier, Hannelore Ceuppens, Hélène Salmon, Cleo Goyvaerts
- Emerging applications of nanobodies in cancer therapy(2022)
Auteurs: R M Awad, Fien Meeus, Hannelore Ceuppens, T Ertveldt, Heleen Hanssens, Q Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W M De Groof, et al.
Pagina's: 143-199